Q J Med 1996; 89: 145-150
© 1996 Association of Physicians
Angiotensin-converting-enzyme inhibitors in the management of cardiac failure: are we ignoring the evidence?
Department of Medicine and Therapeutics, University of Aberdeen UK 1 Department of Cardiology, Aberdeen Royal Infirmary, Foresterhill Aberdeen, UK
Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen AB9 2ZD
Received 7 August 1995 Accepted for publication 5 September 1995.
 |
Abstract |
|---|
The benefits of angiotensin-converting enzyme (ACE) inhibition in the management of cardiac failure have been extensively documented. However, little is known about its impact upon the investigation and management of this condition. We assessed how patients diagnosed as having cardiac failure were investigated, which patients were treated with ACE inhibitors and with what dosages. We reviewed the case notes of all 343 patients discharged from Aberdeen Royal Infirmary 1 July-31 December 1992 with a diagnosis of cardiac failure. In addition, a questionnaire was sent to the general practitioners of the 166 patients still alive in October 1994. Only 40% of patients were discharged from hospital on ACE inhibitors. In 58.8%, the diagnosis of cardiac failure was based purely on clinical or radiological grounds. At discharge, 76.1% of patients were on lower doses of ACE inhibitors than those used in the major survival studies; with 68.9% receiving similar doses two years later. The majority of patients with heart failure are underinvestigated and under-treated.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J G F Cleland Contemporary management of heart failure in clinical practice Heart, October 1, 2002; 88(90002): ii5 - 8. [Full Text] [PDF]
|
|
|
|
 |
|
 K. MacIntyre, S. Capewell, S. Stewart, J.W.T. Chalmers, J. Boyd, A. Finlayson, A. Redpath, J.P. Pell, and J.J.V. McMurray Evidence of Improving Prognosis in Heart Failure : Trends in Case Fatality in 66 547 Patients Hospitalized Between 1986 and 1995 Circulation, September 5, 2000; 102(10): 1126 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G F Cleland Improving patient outcomes in heart failure: evidence and barriers Heart, September 1, 2000; 84(90001): 8i - 10. [Full Text]
|
|
|
|
 |
|
 A Cohen-Solal, M Desnos, F Delahaye, J.P Emeriau, and G Hanania A national survey of heart failure in French hospitals Eur. Heart J., May 1, 2000; 21(9): 763 - 769. [Abstract] [PDF]
|
|
|
|
 |
|
 A. P Davie and J. J McMurray ACE inhibitors and heart failure in hospital: any difference between cardiologists and general physicians? Postgrad. Med. J., April 1, 1999; 75(882): 219 - 221. [Abstract] [Full Text]
|
|
|
|
|
|
J Feenstra, D E Grobbee, F A M Jonkman, A W Hoes, and B H C. Stricker Prevention of relapse in patients with congestive heart failure: the role of precipitating factors Heart, November 1, 1998; 80(5): 432 - 436. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Gambassi, P. Carbonin, R. Bernabei, and R. R. Peto Angiotensin-Converting Enzyme Inhibitors for Elderly Patients With Congestive Heart Failure Arch Intern Med, January 12, 1998; 158(1): 97 - 98. [Full Text] [PDF]
|
|